Saliva and Plasma Exosomes for Oral Leukoplakia Malignant Transformation Diagnosis and Oral Cancer Prognosis Monitoring

CompletedOBSERVATIONAL
Enrollment

225

Participants

Timeline

Start Date

June 13, 2020

Primary Completion Date

June 30, 2023

Study Completion Date

July 30, 2023

Conditions
Oral LeukoplakiaOral Cancer
Interventions
OTHER

Detect the expression level of miR-185 in salivary and plasma exosomes.

"Participants were instructed to refrain from eating, drinking, brushing their teeth, rinsing their mouth, or taking medications for one hour before saliva collection. They were then asked to bend over, lower their head, open their mouth, and allow saliva to flow naturally without chewing or spitting. Using a specialized container, 2 mL of unstimulated saliva was collected.~Participants fasted overnight before blood collection. Researchers used plasma tubes containing anticoagulant (EDTA) to obtain venous blood (4-5 mL) from the participants\' upper arm. Subsequently, the blood was gently inverted to ensure optimal contact with the anticoagulant before centrifugation at 2000 rpm and 4°C for 10 minutes. Following centrifugation, the supernatant was extracted."

Trial Locations (1)

100010

Beijing Stomatological Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Beijing Stomatological Hospital, Capital Medical University

OTHER

NCT06469892 - Saliva and Plasma Exosomes for Oral Leukoplakia Malignant Transformation Diagnosis and Oral Cancer Prognosis Monitoring | Biotech Hunter | Biotech Hunter